Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / OGN - Organon launches biosimilar of cancer drug Herceptin in Canada

OGN - Organon launches biosimilar of cancer drug Herceptin in Canada

Organon & Co.

  • Organon ( NYSE: OGN ) said Ontruzant, a biosimilar of Roche's ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) cancer drug Herceptin, to treat Canadian adults with early breast cancer (EBC), metastatic breast cancer (MBC) and metastatic gastric cancer (MGC) was now available in Canada.
  • Organon said Ontruzant was developed and manufactured by its collaborator Samsung Bioepis.
  • The company said Ontruzant represents Organon Canada's second oncology product available for patients with certain forms of cancers.

For further details see:

Organon launches biosimilar of cancer drug Herceptin in Canada
Stock Information
Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com
Menu
OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...